Calithera Biosciences (NASDAQ:CALA) Earns Hold Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research note issued to investors on Saturday morning. The brokerage issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Stock Down 37.5 %

CALA opened at $0.01 on Friday. The stock has a 50-day moving average price of $0.02 and a 200-day moving average price of $0.02. Calithera Biosciences has a 1 year low of $0.00 and a 1 year high of $0.13.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.